… (D) The percentage of genes significantly overexpressed in the 5 inflammation modules for
each disease. (E) The fold change of the expression of the genes present in the inflammation …

… We thank JB Wing and D. Adeegbe for critically reading the manuscript; the patients, their
families, the nurses, and the healthy donors; and the members of the Flow Cytometry Core …

… and/or echocardiography (n = 28), and pulmonary embolism was excluded by using computed
tomographic pulmonary angiography (n = 35) or low clinical probability with a negative D-…

… leading to hypercalcemia being particularly frequent (34%), notably during summer (50%),
probably due to an insufficient renal excretion of calcium in the context of abnormal vitamin D …

Multiple problems may be encountered during the diagnosis of sarcoidosis: at first diagnose
sarcoidosis in an appropriate clinical setting, secondly, identify any manifestation to be …

… was 20 mg/d in the MMF group and 40 mg/d in the MTX group. The median steroid dosage
at the time of relapse was 5 mg/d in the MMF group and 12.5 mg/d in the MTX group (p = 0.08…

Central nervous system localizations of sarcoidosis may be refractory to conventional treatment
such as steroids and immunosuppressive drugs. Infliximab, a TNF-α antagonist chimeric …

… from which D. Bouvry and L. Mouthon retrospectively reviewed the medical, biological
and pathological records, while all chest CT scans were reviewed by PY. Brillet and D. …

Introduction The off-label use of TNF antagonists in refractory sarcoidosis is increasingly
reported but data on their efficacy and safety are still insufficient. Objective To report on efficacy …

… We calculated the CPI with the following formula: C P I = 91 − ( 0,65 × p e r c e n t p r e d i c
t e d D L C O ) − ( 0,53 × p e r c e n t p r e d i c t e d F V C ) + ( 0,34 × p e r c e n t p r e d i c t e d …